Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance
2021 · Allergology International · 19 citations
https://doi.org/10.1016/j.alit.2021.01.001
Y
Yuka Kashitani
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Yuka Kashitani is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat